Optimization for Chick Performance Bangkok, Thailand 12 th March 2013
|
|
|
- Cornelius Jennings
- 5 years ago
- Views:
Transcription
1 Optimization for Chick Performance Bangkok, Thailand 12 th March 2013 Marcelo PANIAGO, DVM, MSc, MBA Director Global Veterinary Services - Poultry Ceva Santé Animale Libourne - France
2 Evolution of the poultry industry Protection against mortality Protection against mortality No post-vaccination reactions Reduction of shedding Easy to apply (hatcheries) No interference with MDA Long lasting immunity Cost effectiveness Etc etc etc
3 Evolution of the vaccines This early Chinese print shows a vaccination needle Edward Jenner Louis Pasteur Gaston Ramon Watson & Crick
4 Evolution of the vaccines EVOLUTION OF THE POULTRY VACCINES Less attenuated strains Mesogenic ND strains H-52 CEO ILT vaccines More reactive Less valences ND killed vaccine Safer vaccines Enterotropic ND strains Vector ILT or ND vaccines More convenient vaccines Evade MDA Application in the hatcheries Concentrated vaccines Concentrated ND killed vaccines More valences ND+IB+EDS+IC+SE killed vaccine Combinations Immune complex + vector ND vaccine
5 Evolution of the vaccines EVOLUTION OF THE POULTRY VACCINES First description of the disease Mesogenic strains, HB1 and LaSota strain Cloned ND vaccines Introduction of vector vaccines s 40 s 70 s 80 s 90 s 00 s First studies on attenuation of virulent NDV Thermo stable strains (V4 strain) Apathogenic enteric strains
6
7 63-00
8
9 Protection (%) Source: Bennejean et al., 1978 Interference % protection / challenge Live vaccines Chickens Vaccinated Control With MDA Without Age (days)
10 Protection (%) Source: Bennejean et al., 1978 Interference % protection / challenge Inactivated vaccines Chickens Vaccinated Control With MDA Without Age (days)
11 Live + Inactivated ND Vaccines INTERFERENCE WITH MDA % Protection 100 Control Live ND vaccine Inactivated ND vaccine Age (days) Source: Bennejean et al., 1978
12 Live + Inactivated ND Vaccines INTERFERENCE WITH MDA % Protection Control Live ND vaccine Inactivated ND vaccine Live + Inactivated ND vaccines Age (days) Source: Bennejean et al., 1978
13
14 Immune complex IBD vaccine Winterfield 2512 Vaccine virus + Specific Antibodies (Virus Protecting Immunoglobulin) IBDV
15 How does it work? Day-old (0,1ml SQ) In-ovo (0,05 ml)
16 How does it work? Day-old (0,1ml SQ) In-ovo (0,05 ml)
17 Follicular Dendritic Cell (FDC) How does it work?
18 Individual Adjustment Y Y Bursa of Fabricius Bursa of Fabricius
19 Cell Associated Herpesvirus Marek s Disease (HVT) Cell to cell spread of herpesvirus MDV in nucleus R.L. Witter and K.A. Schat D.C. Johnson and J.D. Baines 19
20 Evading NDV Maternal Antibodies (MDA NDV ) Classical Live ND Vaccine rhvt-ndv NDV MΦ X MΦ MΦ Adapted from Moore-Dorsey, K. (2011)
21
22
23 Detection of vhvt-ndv vaccine virus in the spleen Vaccination positives/sampled % of positives D14 D21 D14 D21 vhvt-ndv 10/10 10/10 100% 100% vhvt-ndv & TRM 10/10 10/10 100% 100% Control 0/5 0/5 0% 0%
24 100% detection of vhvt-ndv in the spleen
25 Humoral immune response (HI) n.a. b b a b b a a a Positivity limit Different letters indicate statistically different groups!
26 100% detection of vhvt-ndv in the spleen No interference to ND HI immune response
27 Clinical protection against ND challenge (Malaysian genotype VII)
28 100% detection of vhvt-ndv in the spleen No interference to ND HI immune response No interference to ND protection vvndv challenge (Malaysian isolate Gen. VII)
29 Protection against ND shedding (Malaysian genotype VII) Challenge at week3 Challenge at week 6 b b a b b a a a a a b b a b b a a a a a Different letters indicate statistically different groups; positivity limit is shown with a red line No survivals in the control groups at 7 dpch after both challenges!
30 100% detection of vhvt-ndv in the spleen No interference to ND HI immune response No interference to ND protection vvndv challenge (Malaysian isolate Gen. VII) No interference to NDV shedding reduction
31 Protection against Marek s Disease Challenge at 8 days and lesions verification up to 76 days post challenge 82% 98% 30%
32 100% detection of vhvt-ndv in the spleen No interference to ND HI immune response No interference to ND protection vvndv challenge (Malaysian isolate Gen. VII) No interference to NDV shedding reduction No interference to MD protection RB1B challenge strain
33 Detection of Transmune take (histophatological bursal lesions) Bursa histology (% positives) Groups vhvt-ndv+trm (Marek diluent) TRM (PBS as diluent) D18 D21 D25 D28 D32 D35 0% 0% 40% 90% 100% 100% 0% 60% 70% 80% 90% 100%
34 100% detection of vhvt-ndv in the spleen No interference to ND HI immune response No interference to ND protection vvndv challenge (Malaysian isolate Gen. VII) No interference to NDV shedding reduction No interference to MD protection RB1B challenge strain No interference on Transmune take Bursa histopathological lesions
35 Optimization for Chick Performance Bangkok, Thailand 12 th March 2013 Marcelo PANIAGO, DVM, MSc, MBA Director Global Veterinary Services - Poultry Ceva Santé Animale Libourne - France
36 The future New vaccines, based on new technologies will progressively be part of our day to day vaccination programs. Vaccination in the hatchery will become the rule.
37 Hatchery equipment : DESVAC A company of the CEVA Group * DOVAC Day- old injection * Hatch sprayer cabinet * IMVAC * WINGVAC
38 In- ovo equipment ECAT In Ovo
39
40 Example of Ceva s offer
41
Vectormune ND a step towards control of Newcastle Disease
Poultry Vaccinology Summit April 28-30, Budapest, Hungary Vectormune ND a step towards control of Newcastle Disease Yannick Gardin 1, Vilmos Palya 1, John Elattrache 1, Marcelo Paniago 2, Christophe Cazaban
ESSENTIAL PROTECTION
ESSENTIAL PROTECTION for better life BROILER ND K VITABRON L VITAPEST L NEW L Supported by C H I C K P R O G R A M CONVENTIONAL vaccine range against Newcastle Disease CEVA HATCHERY I MMUNIZATION CONTROL
Dr.Christophe Cazaban
Dr.Christophe Cazaban Technical Manager Biology Innovation Strategy Department. Ceva Sante Animale, France Graduated from the French Veterinary University of Lyon in 1993 He completed his education with
WPSA & WVPA Scientific Conference Roberto Soares, DVM, MAM, ACPV Regional Technical Manager - Poultry Ceva Animal Health APAC Malaysia
WPSA & WVPA Scientific Conference 2013 Roberto Soares, DVM, MAM, ACPV Regional Technical Manager - Poultry Ceva Animal Health APAC Malaysia Outlook the presentation Major changes in the Asia Poultry Industry
RECOMBINANT VACCINES Live or Killed
Antigens and Vaccines Molecular biology drives Innovation Antigen Gene of Interest Recombination RECOMBINANT VACCINES Live or Killed Antigens and Vaccines Molecular biology drives Innovation Antigen Gene
Veterinarian Graduated in Brazil and MSc in Preventive Veterinary Medicine Professor of Poultry Disease at University Federal de Minas Gerais
Dr.Marcelo Paniago Regional Market Manager Ceva Animal Health, Asia Pacific Veterinarian Graduated in Brazil and MSc in Preventive Veterinary Medicine Professor of Poultry Disease at University Federal
Biological monitoring of vaccine take and productive parameters in broilers vaccinated with
Biological monitoring of vaccine take and productive parameters in broilers vaccinated with immune complex and recombinant vector vaccines against Infectious Bursal Disease (IBD) Luiz SESTI 1, Carlos Kneipp
2007 : Became Poultry Corporate Marketing Director. Ceva Sante Animale, France
Dr. Sylvain Comte Poultry Corporate Marketing Director Ceva Sante Animale, France Graduated as a Veterinary in 1993 from National Veterinary School of Nantes France Master of science in Physiology and
Director Biology Innovation Strategy Department. Ceva Sante Animale, France
Dr.Yannick Gardin Director Biology Innovation Strategy Department. Ceva Sante Animale, France Graduated as a Doctor in Veterinary Medicine, from Veterinary School of Lyon France 1977 : Join Ceva as Technical
Graduated from Kyoto University, Graduate School of Agriculture, Japan M.S degree on Molecular Biology and Microbiology.
Dr.Moto Esaki Senior Chief Reseacher Ceva Japan K.K Graduated from Kyoto University, Graduate School of Agriculture, Japan M.S degree on Molecular Biology and Microbiology. 1999 : Joined Biology department
Ceva s offer to optimize performance Simpler vaccination and better safety
Ceva s offer to optimize performance Simpler vaccination and better safety Rick van Oort Poultry Corporate Range Manager Layer range CEVA Sante Animale Bangkok-Thailand March 12, 2013 Bodyweight (g) 1600
AviagenBrief. Marek s Disease Control in Broiler Breeders
AviagenBrief January 2018 Marek s Disease Control in Broiler Breeders Author: A. Gregorio Rosales DVM, MS, PhD, DACPV - Poultry Health Consultant Introduction Marek s Disease Virus (MDV), a highly infectious
Press Pack. Ceva launches VECTORMUNE AI, a novel technology vaccine for H5 Avian Influenza protection
Press Pack Ceva launches VECTORMUNE AI, a novel technology vaccine for H5 Avian Influenza protection Content 1) Summary 2) Definition of the vaccine 3) Safety 4) Efficacy 5) Additional advantages 6) Vectormune
Ceva HAND book of poultry diseases
IVAN DINEV & CEVA Volume 1 Ceva HAND book of poultry diseases GUMBORO CHICKEN ANaEMIA REOVIRUS MAREK RUNTING-STUNTING SYNDROME NEWCASTLe DISEASE AVIAN INFLUENZA INFECTIOUS BRONCHITIS LARyNGOTRACHEITIS
Advances in Marek s Disease Vaccine Development:
Advances in Marek s Disease Vaccine Development: Michel Bublot, DVM, PhD - Merial R&D Asian Avian Forum 2016, Tokyo, July 12-13 Marek s Disease Control Good flock management Cleaning, disinfection Adequate
Is Newcastle disease still a threat for the poultry industry?
Is Newcastle disease still a threat for the poultry industry? Marcelo PANIAGO Director Global Veterinary Services - Poultry Ceva Santé Animale Libourne - France Newcastle Disease in the world Newcastle
Infectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD
Research note Infectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD Grogan K. 1 1 Poultry Chicken Scratch, LLC, 30019 Dacula GA United States of America [from Hoerr F.J., 2010,
Gumboro symposium 19 th & 20th of January 2012 BUDAPEST. Dr Sylvain COMTE Head of Poultry Franchise Poultry Corporate Marketing Director FRANCE
Ceva s Vision in poultry vaccination Gumboro symposium 19 th & 20th of January 2012 BUDAPEST Dr Sylvain COMTE Head of Poultry Franchise Poultry Corporate Marketing Director FRANCE Yann Arthus Bertrand
investing our GLOBAL RESOURCES FUTURE of in the POULTRY We ll be thereṭm
investing our GLOBAL RESOURCES in the FUTURE of POULTRY We ll be thereṭm 2 As the world has become interconnected, the need for a global perspective to animal health has never been more important. An outbreak
Heading to better Process control and Performances
Dr Sylvain Comte Dr. Comte graduated as veterinarian in 1993 be The National of Veterinary School of Nantes (France). Master of Sciences in Physiology and Agronomy be Rennes University (France). He started
CEVAC CEVAC BROILER ND K / 5000 doses
CEVAC BROILER ND K / 5 doses CEVAC BROILER ND K Newcastle disease a permanent threat Newcastle Disease is highly contagious and exists in a wide range of forms. It is one of the four major poultry diseases
YOU THINK INFLUENZA IS FATAL? THINK AGAIN.
YOU THINK INFLUENZA IS FATAL? THINK AGAIN. HVT vector vaccine for H5 Avian Influenza protection Avian influenza Avian influenza remains a major threat for the global poultry industry. Among the different
making LT protection safer and easier
making LT protection safer and easier 1 vaccine up to 3 immunities 4 Vectormune FP-LT and. Vectormune FP-LT is a genetically engineered live fowl pox virus vaccine carrying 2 immunorelevant genes from
The Review of Newcastle Disease Live Vaccines Application. By: M. Abdoshah
The Review of Newcastle Disease Live Vaccines Application By: M. Abdoshah Introduction Only one serotype (PMV1) Maternally derived antibodies are protective All vaccines are efficacious Is vaccine protection
Laboratory Clinical Study
V. Perez et al. Merial Avian Bulletin 3 (2008) Page 3 to 7 Laboratory Clinical Study Anatomopathological analysis of lymphoid organs and serological analysis of chickens vaccinated with a turkey Herpesvirus
Implications and implementation of dayold chick vaccination
Implications and implementation of dayold chick vaccination FAO technical meeting Beijing, 3 December 2013 Sophie von Dobschuetz On behalf of the meeting participants 1 Meeting background and objectives
Vaccines of today and products needed for the short-, intermediate- and longterm. OIE/FAO OFFLU Conference Beijing China December 4-6, 2013
Vaccines of today and products needed for the short-, intermediate- and longterm XU, Wei-Cheng OIE/FAO OFFLU Conference Beijing China December 4-6, 2013 1 Influenza A reservoir & transmission H3N8, (H5N1)
PATHOLOGICAL AND IMMUNOLOGICAL STUDY OF AN IN OVO COMPLEX VACCINE AGAINST INFECTIOUS BURSAL DISEASE
Acta Veterinaha Hungahca 48 (4), pp. 443-454 (2000) PATHOLOGICAL AND IMMUNOLOGICAL STUDY OF AN IN OVO COMPLEX VACCINE AGAINST INFECTIOUS BURSAL DISEASE Maria KELEMEN'*, KatalinFORGACH 1, JuditlVAN 2, V.
Universal protection against infectious bursal disease (IBD) induced by the vector vaccine VAXXITEK HVT+IBD
Review Universal protection against infectious bursal disease (IBD) induced by the vector vaccine VAXXITEK HVT+IBD Lemiere S. 1 & Rojo F. 2 1 Merial S.A.S., 29 avenue Tony Garnier 69348 Lyon cedex 07 France
Response of the Embryo to in ovo
Response of the Embryo to in ovo Vaccination with IBDV Jagdev Sharma a The Biodesign Institute Arizona State University Tempe, Arizona, U.S.A. BUDAPEST 37 Billion chickens produced yearly y IBDV A highly
Gumboro Disease: where are we with IBDV epidemiology. J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands
Gumboro Disease: where are we with IBDV epidemiology J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands Gumboro-virus (IBDV) Avibirna-virus: 2 segments of dsrna Non enveloped virus
GUMBORO FIELD EXPERIENCES IN SPAIN THINGS WE HAVE LEARNT!
GUMBORO FIELD EXPERIENCES IN SPAIN THINGS WE HAVE LEARNT! JOSÉ LUIS VALLS GARCIA Veterinario consultor avícola Barcelona, 15th March 2016 GUMBORO is an Enzootic disease : Challenge will come immediately
Her future looks bright
Her future looks bright ceva rispens vaccines Titre Sous titre Lorem ipsum icam no. Fortusequam ideless itatem quiation con. Ratias vene poreped quamusapicia volupta erspelleni. Flexibilit lorem ipsumnectio
Vector Newcastle vaccine usage in Latin America. Luiz Sesti, Technical Services Latin America Ceva, Brazil
Vector Newcastle vaccine usage in Latin America. Luiz Sesti, Technical Services Latin America Ceva, Brazil Countries with endemic velogenic Newcastle Disease (ND) in Latin America Mexico Guatemala Belize
Research note. Merial S.A.S., 29 avenue Tony Garnier Lyon cedex 07 France 2
Research note Monitoring of vaccine take by quantitative realtime polymerase chain reaction following different Marek s disease vaccination programs in future broiler breeders Delvecchio A. 1, Gimeno I.
Vector vaccines and immunity. Thierry Van den Berg Coda Cerva, Belgium
Vector vaccines and immunity Thierry Van den Berg Coda Cerva, Belgium Overview of the presentation o Theory Background Classical vaccines New technology vaccines Chicken immunology o Laboratory Tools for
Marek s disease and vaccination Presented by Dr Peter Makang a
Challenge poultry Marek s disease and vaccination Presented by Dr Peter Makang a Economic impact of MD on the global poultry industry: 1 to 2 billion USD / year Jozsef MAREK (1868 1952) Multiple Nervenenzündung
Summary of Product Characteristics
Health Products Regulatory Authority Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Novamune concentrate and solvent for suspension for injection for chickens 2 QUALITATIVE
Diagnostic Considerations for Marek s Disease. Frederic J. Hoerr, DVM, PhD AMEVEA - Argentina Colon, Entre Rios May 15, 2013
Diagnostic Considerations for Marek s Disease Frederic J. Hoerr, DVM, PhD AMEVEA - Argentina Colon, Entre Rios May 15, 2013 Control of Marek s Disease Accurate diagnosis Apply appropriate procedures to
«Together we are building a new reference to create value beyond animal health»
Ceva in key figures... Sales 2010: 468 million (v 2009 395 million) Annualgrowth: 18.5% - R&D expenditure: 9% of sales Number of employees: 2543 Present: 40 countries - R&D centers 11 - Production sites
Hatchery Vaccination Quality Control of Herpesvirus of Turkey-Infectious Bursal Disease HVT-IBD Viral Vector Vaccine Application by Specific qpcr
International Journal of Poultry Science 11 (9): 570-576, 2012 ISSN 1682-8356 Asian Network for Scientific Information, 2012 Hatchery Vaccination Quality Control of Herpesvirus of Turkey-Infectious Bursal
http://www.ibs.upm.edu.my Challenges in controlling viral diseases of poultry Abdul Rahman Omar Institute of Bioscience Faculty of Veterinary Medicine Universiti Putra Malaysia aro@upm.edu.my Outline of
Control of Gumboro Disease
Control of Gumboro Disease using an Immune-Complex IBD Vaccine Branko Alva DVM, Poultry Specialist Global Product Manager Controlling Poultry Diseases NON RESIDENT DISEASES Newcastle Diseases Avian Influenza
INTRODUCTION. J.-H. Roh,,1 M. Kang,,1 B. Wei, R.-H. Yoon, H.-S. Seo, J.-Y. Bahng, J.-T. Kwon, S.-Y. Cha,,1 and H.-K. Jang,2
Efficacy of HVT-IBD vector vaccine compared to attenuated live vaccine using in-ovo vaccination against a Korean very virulent IBDV in commercial broiler chickens J.-H. Roh,,1 M. Kang,,1 B. Wei, R.-H.
CHARACTERISATION OF INFECTIOUS BURSAL DISEASE VIRUS AND DETERMINATION OF POSSIBLE VACCINE STRAIN(S) IN KENYA
CHARACTERISATION OF INFECTIOUS BURSAL DISEASE VIRUS AND DETERMINATION OF POSSIBLE VACCINE STRAIN(S) IN KENYA Investigator: Dr. Mutinda, W.U (BVM, MSc.) Supervisors: Prof. P.N Nyaga, BVM, MSc, PhD Prof.
CevaC Mass L THe Ceva Mass solution
CevaC Mass L THe Ceva Mass solution Ceva Santé Animale S.A. - 10, av. de la Ballastière - BP 126-33500 Libourne Cedex - France Tel : + 33 5 57 55 40 40 - Fax : + 33 5 57 55 41 92 www.ceva.com CEVAC MASS
Laboratory tools for monitoring and understanding IBDV infection and vaccination
Laboratory tools for monitoring and understanding IBDV infection and vaccination J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands Gumboro-virus (IBDV) Avibirna-virus: segments of
DURATION OF IMMUNITY OF LIVE VACCINE CEVAC S.
DURATION OF IMMUNITY OF LIVE VACCINE CEVAC S. Gallinarum TESTED BY Salmonella Enteritidis AND Salmonella Gallinarum CHALLENGES, 11 WEEKS AFTER VACCINATION József Herczeg1, Ágnes Makai1, Imre Héjja1, Éva
Laboratory Evaluation of Live Recombinant HVT-IBD Vaccine.
Laboratory Evaluation of Live Recombinant HVT-IBD Vaccine Rania Aly 1 ; El-Sanousi, A 2 and Susan, S. El-Mahdy 1 1 Central Lab. for Eval. of Vet. Biol. Abbassia Cairo, Egypt (CLEVB) 2 Faculty of Vet. Med.
Vaccine Application: Experience of a Daily Management. Ceva Poultry Vaccinology Summit-Budapest April 30 th 2015
Vaccine : Experience of a Daily Management Ceva Poultry Vaccinology Summit-Budapest April 30 th 2015 Vaccine 1 - Vaccine 3 Sub-cutaneous. 2 In-Ovo 4 Spray 2 Vaccinology Summit 2015 - Budapest Vaccine 1
Research Update: Avian Disease & Oncology Lab (ADOL) and SEPRL Endemic Poultry Virus Diseases (EPVD)
Research Update: Avian Disease & Oncology Lab (ADOL) and SEPRL Endemic Poultry Virus Diseases (EPVD) John Dunn, Hans Cheng, Mohammad Heidari, Huanmin Zhang, Taejoong Kim, Stephen Spatz, Qingzhong Yu USDA-ARS-USPNRC
An update on Marek s disease. Isabel M. Gimeno
An update on Marek s disease Isabel M. Gimeno Content Marek s disease (MD) and Marek s disease virus (MDV) evolution MDV-IS: the newest challenge of MDV infection MDV-induced tumors: Analysis of a MD outbreak-
MG and MS Control in Layers
MG and MS Control in Layers Bernie Beckman, DVM Hy-Line International Hy-Line International Genetic Excellence Respiratory Diseases of Poultry Bacterial Diseases M. gallisepticum M. synoviae Coryza - Avibacterium
by Dr Thijs van Dijk and Anna-Christina Riebau Marketing Poultry Vaccines, Lohmann Animal Health
Gumboro vaccination a matter of timing ive IBD vaccines are categorised by their break- titre, virulence and Lthrough potential to induce immune suppression, into mild, intermediate and intermediate plus.
C E E Z A D. Rational Development of Influenza Vaccines: NDV-based influenza vaccines for poultry and livestock
C E E Z A D Center of Excellence for Emerging and Zoonotic Animal Diseases A Department of Homeland Security Center of Excellence Rational Development of Influenza Vaccines: NDV-based influenza vaccines
General context and objectives of the project. Public private partnership (PPP) in Veterinary Public Health. EVADOC project Bangladesh Jan-June 2015
Modeling the effectiveness of avian influenza vaccination strategies in Bangladesh: evaluation of the added value of day old chick vaccination in hatcheries General context and objectives of the project
Benefits Beyond Protection Porcine Pleuropneumonia: From A Good Detection To. A Good Protection. Stress: COGLAPIX.
Hatcheries & Broilers Layers & Breeders I s s u e 8 M a r c h 2 9 A s i a P a c i f i c CEVAC TRANSMUNE IBD: CEVAC TRANSMUNE IBD: The Life The Life Cycle Of An Cycle Of An ImmuneComplex Vaccine ImmuneComplex
Host Genetic Resistance Sustains HVT Protective Efficacy Comparable to CVI988/Rispens in Lines of Chickens Relatively Resistant to Marek s Disease
Host Genetic Resistance Sustains HVT Protective Efficacy Comparable to CVI988/Rispens in Lines of Chickens Relatively Resistant to Marek s Disease Huanmin Zhang 1, Shuang Chang 1, 2, John R. Dunn 1 Mohammad
ZOOTECNICA. International WORLD S POULTRY JOURNAL
ZOOTECNICA WORLD S POULTRY JOURNAL International Assessment of the immune response in broilers and pullets using two ELISA kits after in ovo or day-old vaccination with a vectored HVT + IBD vaccine (VAXXITEK
Comparison of the Efficacy of the Immune Complex and Conventionally Live Vaccine in Broilers against Infectious Bursal Disease Infection
Chansiripornchai N. & Sasipreeyajan J./Thai J. Vet. Med. 39(2): 115-120. 115 Original Article Comparison of the Efficacy of the Immune Complex and Conventionally Live Vaccine in Broilers against Infectious
ABSTRACT INFECTIOUS BURSAL DISEASE VIRUS VACCINES IN OVO. broiler producers throughout the world. An in ovo delivery system for plasmid DNA
ABSTRACT Title of Dissertation: DELIVERY OF DNA AND RECOMBINANT INFECTIOUS BURSAL DISEASE VIRUS VACCINES IN OVO Lenita Moura, Doctor of Philosophy, 2004 Dissertation directed by: Professor Vikram N. Vakharia
AL-Qadisiya Journal of Vet.Med.Sci. Vol./11 No./1 2012
Post-vaccinal reaction for some vaccines used against Newcastle disease in Sulaimaniyah province E.A. Abdul Ahad Coll. of Vet. Med.\ Unive. of Sulaimaniyah Abstract This study was conducted to investigate
Interpretation and Application of Results Manual
Interpretation and Application of Results Manual Contents Applications of Results Obtained from BioChek ELISA kits page 3 Good sampling and Sample Size page 4-8 Interpretation of BioChek Results page 9
rhvt/nd-ibd (Project code: R051) Live, genetically modified, frozen virus suspension for injection in broiler and layer pullets
Date: March 8, 2018 Reference: rhvt/nd-ibd BR279/2017 SNIF Number of pages: 18 rhvt/nd-ibd (Project code: R051) Live, genetically modified, frozen virus suspension for injection in broiler and layer pullets
Interaction of Gumboro and other Immunosuppressive Diseases on Respiratory Disease
Interaction of Gumboro and other Immunosuppressive Diseases on Respiratory Disease FREDERIC J. HOERR II SEMINARIO INTERNACIONAL AVICOLA MERIAL PANAMA CITY, PANAMA JULY 10, 2014 Broiler Disease by Age Rickets
Maximising the benefits of Serological Monitoring and Reporting
Maximising the benefits of Serological Monitoring and Reporting AviAfrica, 21-06-2017, Johannesburg Luuk Stooker, DVM Senior Product Manager BioChek Forecast on food Source: Rabobank Forecast on meat consumption
Anja Holm Danish Medicines Agency. Genetic vaccines Oslo, 2008
Anja Holm Danish Medicines Agency Genetic vaccines Oslo, 2008 Legal basis for authorisation Special double environmental assessment Authorised GMO products Anja Holm - GMO vaccines - Oslo 2008 2 Regulation
Retrospective Study of Some Viral Poultry Diseases Diagnosed in Nigeria
International Journal of Basic and Applied Virology 3(1): 16-21, 2014 ISSN 2222-1298 IDOSI Publications, 2014 DOI: 10.5829/idosi.ijbav.2014.3.1.83278 Retrospective Study of Some Viral Poultry Diseases
Infectious Laryngotracheitis Disease Prevalence Patterns
Infectious Laryngotracheitis Disease Prevalence Patterns 2012 Delmarva Poultry Conference Ocean City, MD Daniel A. Bautista, DVM, MS University of Delaware-Lasher Laboratory Elbert N. and Ann V. Carvel
Investigation on the possible application of a serological DIVA monitoring strategy when a rhvt-h5 vaccine is used to control Avian Influenza
AVMA AAAP Convention 2016 August 7, San Antonio, Texas, USA Investigation on the possible application of a serological DIVA monitoring strategy when a rhvt-h5 vaccine is used to control Avian Influenza
Diagnostic Guide for Marek s Disease and other Tumors
Diagnostic Guide for Marek s Disease and other Tumors Veterinary Diagnostic Pathology, LLC Frederic J. Hoerr, DVM, PhD fred.hoerr@gmail.com; 334-750-7566; www.vetdx.com CF.416.1.TumorHistopathologyDiagnosticGuide.FJH.08.26.2013
PRESS RELEASE. Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between
Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between Dr. Marc Prikazsky, Chairman and Chief Executive Officer and Prof. Ren Tao, Vice-Dean
TRUSTWORTHY POULTRY CEVAC CORYMUNE RANGE. Unique combination vaccines to protect against Coryza and Salmonella. Supported by CEVAC CORYMUNE 4K
CEVAC CORYMUNE RANGE Unique combination vaccines to protect against Coryza and Salmonella TRUSTWORTHY POULTRY CEVAC CORYMUNE RANGE Supported by CEVAC CORYMUNE 4K Unique broad combination vaccine against
RVF Vaccination strategies, vaccine availability and quality control. Danny Goovaerts DVM
RVF Vaccination strategies, vaccine availability and quality control Danny Goovaerts DVM Contents Vaccination strategy Epizootic versus endemic virus cycle and strategy Vaccine availability Market aspects,
The Threat of Marek s Disease Virus Is Expanding
The Threat of Marek s Disease Virus Is Expanding The virus responsible for this lymphoproliferative disease is growing more virulent and evading control by available vaccines Kyle S. MacLea and Hans H.
Technical meeting 4-6 December 2013 Beijing
Technical meeting 4-6 December 2013 Beijing Review on cost and financial implications of HPAI vaccination in countries applying HPAI vaccination Jan Hinrichs, Animal Health Economist, FAO Bangkok jan.hinrichs@fao.org
Characterization of Non-oncogenic Marek's Disease Virus-infected and Turkey Herpesvirus-infected Lymphocytes
J. gen. Virol. (1982), 63, 333-341. Printed in Great Britain 333 Key words: turkey herpesvirus/mdv/lyraphocytes Characterization of Non-oncogenic Marek's Disease Virus-infected and Turkey Herpesvirus-infected
CONVENIENCE PROGRAM. An early start in respiratory health for a more profitable life.
CONVENIENCE PROGRAM An early start in respiratory health for a more profitable life. The Convenience Program puts our science and people to work for you Respiratory disease is a global threat to the health
Proposed bursa of fabricius weight to body weight ratio standard in commercial broilers
Proposed bursa of fabricius weight to body weight ratio standard in commercial broilers Christophe Cazaban,,1 Natalia Majo Masferrer,, Roser Dolz Pascual, Miquel Nofrarias Espadamala, Taiana Costa, and
AVIAN VIRAL TUMORS I. MAREK'S DISEASE
DEFINITION The several viral neoplastic diseases of chickens and turkeys, although previously considered a "complex", are actually distinct disease entities. In some cases a single tumor virus strain can
Vaccines - Canine
Vaccines - Canine 803-808-7387 www.gracepets.com What is a vaccine? The word vaccine comes from the discovery of an English country doctor, Dr. Edward Jenner. Dr. Jenner discovered that people given a
Vaccines for Dogs. "Immunity has memory."
Vaccines for Dogs What is a vaccine? The word vaccine comes from the Latin word "vacca", which means cow. An English country doctor, Dr. Edward Jenner, discovered that people given a preparation or vaccine
Etiology. Paramyxovirus type 1 = Newcastle disease.
Newcastle Disease Many strains of similar virus cause signs ranging from mild respiratory signs (pneumotropic) with low mortality to severe neurological (neurotropic) and/or visceral lesions (viscerotropic)
JEAN-CHRISTOPHE AUDONNET
JEAN-CHRISTOPHE AUDONNET Recombinant Veterinary Vaccines Overview of Progress in the past 30 years and Future Trends Jean-Christophe AUDONNET DVM, Ph.D. Merial R&D OUTLINE OF THE TALK 01 02 ORIGIN AND
Public private partnership on a pilot vaccination trial in Egypt
Technical meeting 4-6 December 2013 Beijing Public private partnership on a pilot vaccination trial in Egypt Guillaume BELOT, Gwenaëlle DAUPHIN, Astrid TRIPODI, Sophie Von Dobshuetz, Walid HASSAN, Heba
Understanding Marek s Disease Immunity: A Continuing Challenge
International Journal of Poultry Science 3 (1): 89-95, 2004 Asian Network for Scientific Information 2004 Understanding Marek s Disease Immunity: A Continuing Challenge K.A. Schat Unit of Avian Medicine,
Skin involvement in lymphomas caused by Marek s disease virus infection in Silkie chickens
522462VDIXXX10.1177/1040638714522462Skin involvement in lymphomas in SilkiesLiu et al. research-article2014 Case Report Skin involvement in lymphomas caused by Marek s disease virus infection in Silkie
Poultry Disease Manual Characteristics And
Poultry Disease Manual Characteristics And Control Of Infections Written by: Dr. Jacquie Jacob, University of Kentucky Pullorum disease, also called Infection by Salmonella pullorum has also been reported
Investigations of Avian Leukosis Virus Subgroup J and Reticuloendotheliosis Virus Infections in Broiler Breeders in China
Investigations of Avian Leukosis Virus Subgroup J and Reticuloendotheliosis Virus Infections in Broiler Breeders in China Cheng, Z.,* Zhang, H., Wang G., Liu, Q., Liu, J., Guo, H. and Zhou E. College of
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
[Version 8, 10/2012] Cevac MD HVT_2016-October-18 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cevac MD HVT suspension and solvent for suspension for injection
3. Antibody to PPRS Virus (PRRSV) 4. Antibody to Pseudorabies Virus /gpl Aujeszky s Disease (PRV/ADV gpl) 5. Antibody to Swine Salmonella
1 Swine Serum 1. Antibody to Porcine BioChek, Smart veterinary diagnostics, Circovirus Virus Type 2 (PCV2) Product Code SK105 PCV2 Indirect Enzyme- Linked Immunosorbent Assay 2. Antibody to Classical Swine
Field experience with vaccination in turkeys in Morocco. Taoufik RAWI M.C.I Santé Animale (Morocco)
Field experience with vaccination in turkeys in Morocco Taoufik RAWI M.C.I Santé Animale (Morocco) Field experience with vaccination in turkeys in Morocco Taoufik Rawi, DVM, MBA Head Of Technical Support
FEATHER TIP MONITORING OF MAREK S DISEASE VIRUS IN EXPERIMENTAL AND COMMERCIAL SETTINGS. Milos Markis
FEATHER TIP MONITORING OF MAREK S DISEASE VIRUS IN EXPERIMENTAL AND COMMERCIAL SETTINGS by Milos Markis A thesis submitted to the Faculty of the University of Delaware in partial fulfillment of the requirements
Avian influenza heterologous prime-boost vaccination strategies. Michel BUBLOT Boehringer Ingelheim AH R&D (France)
Avian influenza heterologous prime-boost vaccination strategies Michel BUBLOT Boehringer Ingelheim AH R&D (France) Avian influenza vaccines - History 1970s 1998 2004 2006 2012 2014 Inactivated Fowlpox
11/6/2014. Questions? vvibdv in California : What we think we know and where we re heading. What is Cooperative Extension? Who am I??
? vvibdv in California 2008-2014: What we think we know and where we re heading Maurice Pitesky, DVM, MPVM, Dipl. ACVPM Assistant Specialist in Cooperative Etension, University of California Poultry Health
PART 1 (COUNCIL DECISION 2002/813/EC)
PART 1 (COUNCIL DECISION 2002/813/EC) SUMMARY NOTIFICATION INFORMATION FORMAT FOR THE RELEASE OF GENETICALLY MODIFIED ORGANISMS OTHER THAN HIGHER PLANTS IN ACCORDANCE WITH ARTICLE 11 OF DIRECTIVE 2001/18/EC
Morphological investigation of bursa of fabricius of imported broilers and local chicks vaccinated with two types of ibd vaccines
Morphological investigation of bursa of fabricius of imported broilers and local chicks vaccinated with two types of ibd vaccines M.A.S Abu Tabeekh * and A.A.S.AL- Mayah ** * Veterinary Hospital, Basrah
Dual-Viral Vector Approach Induced Strong and Long-Lasting Protective Immunity against Very Virulent Infectious Bursal Disease Virus
Virology 269, 257 267 (2000) doi:10.1006/viro.2000.0184, available online at http://www.idealibrary.com on Dual-Viral Vector Approach Induced Strong and Long-Lasting Protective Immunity against Very Virulent
Ceva HAND book of poultry diseases
IVAN DINEV & CEVA Volume 2 Ceva HAND book of poultry diseases Salmonellosis CAMPYLOBACTERIOSIS Fowl cholera AVIAN CLOSTRIDIOSIS Coccidiosis mycoplasma GALLISEPTICUM INFECTIONS mycoplasma SYNOVIAE INFECTIONS